70121-1754
ALYMSYS
bevacizumab-maly
INJECTION, SOLUTION
Intravenous
BEVACIZUMAB
100.0
mg/4mL
70121-1754-07
10 VIAL in 1 CARTON (70121-1754-7) > 4 mL in 1 VIAL
April 15, 2022
Immunotherapy
Monoclonal Antibody
VEGF
 
 
In Use